Non Hodgkin Lymphoma Clinical Trial

High Dose Chemotherapy Followed By PBSC Rescue for HD

Summary

To evaluate the role of high dose chemotherapy with autologous hematopoietic cell transplantation in the treatment of Hodgkin's Disease.

View Full Description

Full Description

Use of High Dose Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Relapsed or Resistant Hodgkin's Disease

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:- adequate organ function

recurrent HD Exclusion Criteria:- CNS disease
no prior malignancy

Study is for people with:

Non Hodgkin Lymphoma

Estimated Enrollment:

200

Study ID:

NCT00186251

Recruitment Status:

Completed

Sponsor:

Stanford University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Stanford University School of Medicine
Stanford California, 94305, United States

How clear is this clinincal trial information?

Study is for people with:

Non Hodgkin Lymphoma

Estimated Enrollment:

200

Study ID:

NCT00186251

Recruitment Status:

Completed

Sponsor:


Stanford University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider